Skip to main content
. 2023 Feb 11;91(4):957–967. doi: 10.1111/bcp.15672

TABLE 4.

Acceptability by delamanid dose and formulation.

All participants Disp Disp Disp Whole Whole Whole
25 mg 50 mg 100 mg 25 mg 50 mg 100 mg
n = 98 (%) n = 17 (%) n = 17 (%) n = 16 (%) n = 16 (%) n = 16 (%) n = 16 (%)
Appearance 87 (88.8) 15 (88.2) 16 (94.1) 14 (87.5) 16 (100.0) 11 (68.8) 15 (93.8)
Smell 92 (93.9) 16 (94.1) 16 (94.1) 14 (87.5) 16 (100.0) 15 (93.8) 15 (93.8)
Taste 90 (91.8) 15 (88.2) 17 (100.0) 15 (93.8) 15 (93.8) 13 (81.3) 15 (93.8)
Texture 90 (91.8) 17 (100.0) 15 (88.2) 13 (81.3) 15 (93.8) 16 (100.0) 14 (87.5)
Amount 90 (91.8) 15 (88.2) 17 (100.0) 15 (93.8) 16 (100.0) 12 (75.0) 15 (93.8)
Overall 93 (94.9) 17 (100.0) 16 (94.1) 15 (93.8) 16 (100.0) 13 (81.3) 16 (100.0)
Child‐Taste 83 (84.7) 17 (100.0) 17 (100.0) 16 (100.0) 11 (68.8) 9 (56.3) 13 (81.3)
Child‐Amount 75 (76.5) 17 (100.0) 16 (94.1) 14 (87.5) 12 (75.0) 6 (37.5) 10 (62.5)
Child‐Overall 78 (79.6) 17 (100.0) 14 (82.4) 14 (87.5) 13 (81.3) 9 (56.3) 11 (68.8)

Note: For Likeability and Acceptability, only Likeable and Acceptable values are displayed in this table.

Abbreviations: (%), percentage of the total number of participants per group; Acceptable, neutral, like, like very much; Child‐, if a child was required to take this formulation, how the participant thought the child would feel about the formulation; Disp, delamanid dispersed; Unacceptable, dislike, dislike very much; Whole, delamanid whole tablet(s).